Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology.
<h4>Background</h4>The von Hippel-Lindau tumour suppressor protein-hypoxia-inducible factor (VHL-HIF) pathway has attracted widespread medical interest as a transcriptional system controlling cellular responses to hypoxia, yet insights into its role in systemic human physiology remain li...
Saved in:
| Main Authors: | Thomas G Smith, Jerome T Brooks, George M Balanos, Terence R Lappin, D Mark Layton, Dawn L Leedham, Chun Liu, Patrick H Maxwell, Mary F McMullin, Christopher J McNamara, Melanie J Percy, Christopher W Pugh, Peter J Ratcliffe, Nick P Talbot, Marilyn Treacy, Peter A Robbins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2006-07-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0030290&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans.
by: Tammie Bishop, et al.
Published: (2004-10-01) -
Von Hippel-Lindau Disease and Pheochromocytoma
by: J Gordon Millichap
Published: (1993-12-01) -
Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma
by: P. Vaganovs, et al.
Published: (2013-01-01) -
Cáncer Renal Hereditario Bilateral en Von Hippel Lindau.
by: Pablo Le Masson T., et al.
Published: (2020-12-01) -
Metastatic Renal Cell Carcinoma versus Pancreatic Neuroendocrine Tumor in von Hippel-Lindau Disease: Treatment with Interleukin-2
by: Christopher Williams, et al.
Published: (2005-01-01)